... Complementary studies of the gastrointestinal safety of the cyclo-oxygenase-2-selective inhibitor etoricoxib. Aliment Pharmacol Ther. ... Comparative Effectiveness Review, No. 228.) Appendix J, Appendix References. PDF version of this title (14M) Other titles ...

... Baigent C, Godwin J, et al.: Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti- ... and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal ...

... review of nonsteroidal anti-inflammatory drugs (NSAIDs) found cyclo-oxygenase-2 selective NSAIDs associated with greater myocardial ... or intended effects. For example, the finding that cyclo-oxygenase-2-selective NSAIDS were associated with an ...

... or “Cyclooxygenase 2 inhibitor*” or “Cyclooxygenase inhibitor*” or “Cyclo-oxygenase inhibitor*” or Dapsone or Dexibuprofen or Dexketoprofen ... or “Cyclooxygenase 2 inhibitor*” or “Cyclooxygenase inhibitor*” or “Cyclo-oxygenase inhibitor*” or Dapsone or Dexibuprofen or Dexketoprofen ...

... or “Cyclooxygenase 2 inhibitor*” or “Cyclooxygenase inhibitor*” or “Cyclo-oxygenase inhibitor*” or Dapsone or Dexibuprofen or Dexketoprofen ... or “Cyclooxygenase 2 inhibitor*” or “Cyclooxygenase inhibitor*” or “Cyclo-oxygenase inhibitor*” or Dapsone or Dexibuprofen or Dexketoprofen ...

... or “Cyclooxygenase 2 inhibitor*” or “Cyclooxygenase inhibitor*” or “Cyclo-oxygenase inhibitor*” or Dapsone or Dexibuprofen or Dexketoprofen ... or “Cyclooxygenase 2 inhibitor*” or “Cyclooxygenase inhibitor*” or “Cyclo-oxygenase inhibitor*” or Dapsone or Dexibuprofen or Dexketoprofen ...

... TXA).ti,ab. 7. (cyklokapron or transamin or cyclo-f or femstrual).ti,ab. 8. (transcam or ... rFVII*).ti,ab. 3. (cyklokapron or transamin or cyclo-f or femstrual).ti,ab. 4. (transcam or ...

... crystalline forms of the cyclic heptapeptide antibiotic ternatin, cyclo[-beta-OH-D-Leu-D-Ile-(NMe)Ala-( ... may suppress the development of premalignant colorectal adenomas. References Raja HA, Baker TR, Little JG, et al.: ...

... Peterson K, et al. Drug class review on cyclo-oxygenase (COX)-2 inhibitors and non-steroidal anti- ... C3. Summary of methodologic publications regarding clinical heterogeneity References 1. Adams KFJ. Post hoc subgroup analysis and ...

... Wang H, et al. Predictors of response to cyclo-oxygenase-2 inhibitors in osteoarthritis: pooled results from ... VW, Suen BY, et al. Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor ...